Multiple myeloma
Conditions
Interventions
Observation group:None
Sponsors
Shengjing Hospital of China Medical University
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: To be included in the study treatment, patients must meet the following criteria: Participants must meet all of the following conditions in order to be selected for this study: 1. Male or female patients aged 18 or above. 2. Before conducting any research related procedures that do not fall under standard medical care, voluntary written consent must be provided, but patients may withdraw their consent at any time without affecting future medical care. 3. Previously untreated and symptomatic multiple myeloma, all patients meet the diagnostic criteria listed in the 2022 Chinese Guidelines for the Diagnosis and Treatment of Multiple Myeloma. 4. Gastrointestinal diseases without clear diagnosis. 5. Female patients who have been postmenopausal for at least one year, or have undergone surgical sterilization or if they are capable of reproduction, must agree to use effective contraceptive methods from the date of signing the informed consent form until 90 days after the last dose of the study drug;Male patient agrees to adopt effective contraceptive methods throughout the entire study treatment period and 90 days after the last dose of study medication. 6. There are follow-up conditions available. The patient understands the characteristics of the disease and voluntarily joins the study protocol for treatment and follow-up.
Exclusion criteria
Exclusion criteria: Any of the following points shall be used as exclusion criteria: 1. According to the protocol or the researcher's judgment, patients with serious physical or mental illnesses may interfere with their participation in this clinical study; 2. Drug abuse, medical, psychological, or social conditions that may interfere with subject participation in research or evaluation of research results; 3. Pregnant or lactating women; 4. The researchers believe that it is not suitable for the participants.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Microbial diversity of gut microbiota; | — |
Countries
China
Contacts
Public ContactAijun Liao
Shengjing Hospital of China Medical University
Outcome results
None listed